Background
Dr. Jeff W. M. Bulte is a Professor in the Johns Hopkins Departments of Radiology, Oncology, Biomedical Engineering, and Chemical & Biomolecular Engineering. He serves as the Inaugural Director of Scientific Communications in the Department of Radiology, and is Director of Cellular Imaging at the Johns Hopkins Institute for Cell Engineering. He specializes in molecular and cellular imaging.
Dr. Bulte has pioneered methods to label cells magnetically, making them visible by magnetic resonance imaging (MRI) and magnetic particle imaging (MPI). His team is developing in vivo cell tracking techniques, reporter genes and immunoprotective semi-permeable microcapsules detectable by MRI, MPI, computed tomography, ultrasound, and bioluminescent imaging.
Dr. Bulte received his undergraduate degree in biology and a master's in medical biology from the Free University of Amsterdam in The Netherlands. He earned his Ph.D. in medicine summa cum laude from the University of Groningen in the Netherlands in 1991. He subsequently spent 10 years with the National Institutes of Health, first as a postdoctoral fellow and then a staff scientist in the Laboratory of Diagnostic Radiology Research. Dr. Bulte joined the Johns Hopkins faculty as an Assistant Professor in 2001, became an Associate Professor in 2002, and a Professor in 2006.
He is a Fellow and Gold Medal awardee of the International Society of Magnetic Resonance in Medicine, a Fellow of the World Molecular Imaging Society, a Fellow of the American Institute of Medical BioEngineering, and a Distinguished Investigator of the Academy of Radiology Research. He has published over 300 peer-reviewed articles and 50 book chapters, and serves on the editorial boards of Radiology, WIREs Nanomedicine and Nanobiotechnology, Molecular Imaging, the Journal of Magnetic Resonance Imaging, and Tomography.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.